English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background US drug prices are among the highest worldwide as US policy makers have historically been reluctant to embrace price regulations, instead relying on market forces to set prices. However, the introduction of a number of breakthrough, highly effective and high-cost specialty medicines over the past years has stoked the fire of the long-running drug price debate in the USA. The prices of those specialty medicines – more than $100,000 per treatment course – have resulted in widespread outcry among patients, providers, insurers, and members of the Congress and the Senate. We aimed at analyzing whether the recent debate on drug prices reflects a sign of change in the drug pricing debate in US print media.

30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?